An interventional study of Ronnie Gardiner Method in Parkinson Disease (PD), Cognition and Quality of Life, sponsored by University Ghent. Recruiting at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by University Ghent · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 82 studies in Parkinson Disease with a site in Belgium — 19 open to participants now, 23 under way, 2 of them phase 3. Parkinson Disease · Belgium.
Among the 82 studies in Parkinson Disease with a site in Belgium, this one is the 57th largest by planned enrollment of the 65 interventional ones that give a count, is one of 7 that started in 2026, is one of 37 with no phase, reaches primary completion later than 7 of the 22 other live ones, and was the 81st registered.
4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.
Browse Parkinson Disease studies →19 of the 82 studies in Parkinson Disease with a site in Belgium are open now. Recruiting first, the newest first:
AbbVie · Sites in Belgium
Ages 18+
Loes Laurijssen · Sites in Belgium
Ages 18+
Universitaire Ziekenhuizen KU Leuven · Sites in Belgium
Ages 18–90 · Healthy volunteers
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Sites in Belgium, Netherlands
Ages 18+
KU Leuven · Sites in Belgium, Germany, Israel
Ages 18+ · Healthy volunteers
A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →
Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
82 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 6 · Phase 3 18 · Phase 4 1
First in 2002; this study’s year is marked. 7 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 40 across 3,360 interventional studies indexed under Parkinson Disease.
Median enrollment 52 across the 65 interventional studies, 100 across the 17 observational. Of the 53 that completed or were terminated, 11 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
31 of 82 have an industry lead sponsor. The 10 most frequent:
University Ghent is the lead sponsor of 350 studies on the registry; 86 are open to participants now.
University Ghent has 3 studies filed under Parkinson Disease — fewer than ten, so there is no comparison to draw.
8 of the studies in Parkinson Disease with a site in Belgium that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07548801Université Libre de BruxellesCerebellar Transcranial Direct Current Stimulation in Parkinson's Disease | 2026-11 |
| NCT07863219University GhentShort Term Effects of a Multimodal Intervention With RGM on Cognition in People With Parkinson's Disease. | 2026-12-20 |
| NCT06909045Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease | 2027-02-01 |
| NCT06798844Universitaire Ziekenhuizen KU LeuvenSpinal Cord Stimulation for Freezing of Gait in Parkinson's Disease | 2027-05 |
| NCT07863102University Hospital, GhentExtended Reality Rehabilitation in Parkinson's Disease | 2027-05 |
Add all 8 to your calendar (.ics) → With an account.
Among the 82 studies in Parkinson Disease with a site in Belgium, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if the Ronnie Gardiner Method (RGM) works to improve cognitive functions in adults with Parkinson's disease (early to mid-stage). It will also learn about the secondary effects on speech, mobility, balance, and mood.
The main questions it aims to answer are:
The Ronnie Gardiner Method (RGM) is a cheerful, structured, multi-sensory brain exercise method that utilizes rhythm and music to stimulate movement, speech, and cognition. RGM makes playful use of rhythm, music, movement, speech, hearing, sight, and touch. During practice, the participant reads the symbols and 'translates' them into the corresponding movement, which is performed to the rhythm of the music. Preliminary research suggests RGM may have added value in promoting mobility, cognition, and well-being in neurological patients (https://www.tandfonline.com/doi/full/10.1080/09638288.2024.2392037#d1e1192).
The RGM exercise series for which participants are registering is integrated in the "Fit en Actief group classes" organized by the Ghent Flemish Parkinson League - in collaboration with Ghent University Rehabilitation Sciences and Physiotherapy.
The classes will take place from October to December 2026 (10 weeks), with exercises taking place once a week for 1.5 hours (on Thursdays) in the practical classrooms of the Rehabilitation Sciences and Physiotherapy program (UH Ghent, B3). In addition to the exercise sessions themselves, participants will be asked to perform home exercises twice a week for 15 minutes.
Before and after the exercise series, participants will be invited to take a pre- and post-test including administrative data, cognition, motor symptoms, balance, QOL. The training process (home exercises, experiences) will be inventoried by temporary questionnaires.
Afterwards, participants will be surveyed regarding changes in medication during the exercise series, changes in the frequency or content of (physio)therapy, and perceived changes in attention, memory, and planning.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
10 weeks of RGM group training (1.5h/w) supplemented with home exercises and conventional care
Other: Ronnie Gardiner Method
1. Warm-up (10 min): light rhythmic movements to music; activation of coordination and attention. 2. RGM Block 1 (30 min): cognitive-motor exercises incorporating color, sound, and movement elements (bilateral). 3. Strength or interval segment (10 min): short strength/conditioning exercises (Tabata style) alternating between 20 seconds of activity and 20 seconds of rest. The exercises focus on strengthening postural muscles, improving rotation, encouraging weight shifting, and initiating movement quickly (the 4 principles of the PWR! concept). 4. 10-minute break 5. RGM Block 2 (30 min): cognitive-motor exercises incorporating color, sound, and movement elements (bilateral). 6. Cool-down (10 min): relaxation, breathing, evaluation. Cognitive component During the sessions, executive functions, attention, and processing speed are challenged and practiced through dual-task situations, pattern recognition, and auditory response tasks. Home exercises After each session, participants are gi
Also known as: multimodal therapy, group therapy
change in cognition
score on SCOPA-COG
Time frame: From enrollment to the end of intervention at 10 weeks
change in motor symptoms
score of MDS-UPDRS III
Time frame: From enrollment to the end of intervention at 10 weeks
change in balance and mobility
score of MiniBESTest / Functional Gait Assessment
Time frame: From enrollment to the end of intervention at 10 weeks
change in QOL
score of PDQ39
Time frame: From enrollment to the end of intervention at 10 weeks
Speech handicap Index
score of perceived handicap - physical, functional and emotional
Time frame: From enrollment to the end of intervention at 10 weeks
change in quality of voice (vowel formants, voice oncet time), motor speech and prosody
Praat-score (a free, open-source computer program) Motor Speech Profile - score (vocal tremor, diadochokinetic rates, and pitch/formant transitions) Loudness, intonation and speech intelligibility during reading ("The North Wind and the Sun") - 3 minutes of spontaneous speech
Time frame: From enrollment to the end of intervention at 10 weeks
Change in maximum voluntary respiration rate
maximum volontary respiration frequency
Time frame: From enrollment up to 10 weeks of intervention
Plan to share: No
Started Aug 2026 (actual). Primary completion is estimated for Dec 2026, 4 months after the start.
Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 4 months is below that.
Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.